EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Evaluation of Lupus Cases Related to TNF Inhibitors in Children

Şeyma Türkmen, Nelgin Gerenli, Betül Sözeri

The Journal of Pediatric Academy · 2023

DOI: 10.4274/jpea.2023.226 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pediatric Academy, 2023. Verfasst von Şeyma Türkmen und 2 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic lupus erythematosus (SLE) due to anti-tumor necrosis factor (TNF) agents is a rare entity. We reported three cases who developed lupus-like syndrome while receiving infliximab therapy for various reasons. All cases demonstrated clinical and laboratory findings of SLE. And all of them needed treatment. We would like to emphasize that the risk of anti-TNF-alpha-induced lupus should be kept in mind in patients receiving anti-TNF therapy for any reason.

Zitieren

APA

Türkmen, Ş., Gerenli, N., & Sözeri, B. (2023). Evaluation of Lupus Cases Related to TNF Inhibitors in Children. The Journal of Pediatric Academy. https://doi.org/10.4274/jpea.2023.226

Vancouver

Türkmen Ş, Gerenli N, Sözeri B. Evaluation of Lupus Cases Related to TNF Inhibitors in Children. The Journal of Pediatric Academy. 2023. doi:10.4274/jpea.2023.226

BibTeX
@article{Trkmen2023,
  author = {Türkmen, Şeyma and Gerenli, Nelgin and Sözeri, Betül},
  title = {Evaluation of Lupus Cases Related to TNF Inhibitors in Children},
  journal = {The Journal of Pediatric Academy},
  year = {2023},
  doi = {10.4274/jpea.2023.226}
}
Kostenlos starten →